Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation

Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation

Despite the identification of circulating tumor cells (CTCs) and cell-free DNA (cfDNA) as potential blood-based biomarkers capable of providing prognostic and predictive information in cancer, they have not been incorporated into routine clinical practice. This resistance is due in part to technolog...

Full description

Bibliographic Details
Main Authors: Lowes, Lori E., Bratman, Scott V., Dittamore, Ryan, Done, Susan, Kelley, Shana O., Mai, Sabine, Morin, Ryan D., Wyatt, Alexander W., Allan, Alison L.
Format: Online
Language:English
Published: MDPI 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037782/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037782/

Similar Items